BIAF - bioAffinity Technologies, Inc. Stock Price, Fair Value and News

$1.35-0.09 (-6.25%)

Delayed as of 22 Oct 2024, 09:50 am ET

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

BIAF Price Action

Last 7 days

-25.7%

Last 30 days

-32.5%

Last 90 days

-47.9%

Trailing 12 Months

-3.5%

BIAF RSI Chart

BIAF Valuation

Market Cap

19.4M

Price/Earnings (Trailing)

-2.22

Price/Sales (Trailing)

2.65

EV/EBITDA

-2.28

Price/Free Cashflow

-2.73

BIAF Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

BIAF Fundamentals

BIAF Revenue

Revenue (TTM)

7.3M

Rev. Growth (Yr)

12.0K%

Rev. Growth (Qtr)

-0.36%

BIAF Earnings

Earnings (TTM)

-8.7M

Earnings Growth (Yr)

-21.27%

Earnings Growth (Qtr)

-7.57%

BIAF Profitability

Operating Margin

99.99%

EBT Margin

-119.23%

Return on Equity

-254.47%

Return on Assets

-131.24%

Free Cashflow Yield

-36.58%

BIAF Investor Care

Shares Dilution (1Y)

53.14%

Diluted EPS (TTM)

-0.91

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	4.9M	7.3M	0	0
2023	0	847.4K	1.7M	2.5M
2022	0	0	0	4.8K

Get all data in R, Python etc through our Historical Stock Data APIs

About bioAffinity Technologies, Inc.

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level. The company was incorporated in 2014 and is based in San Antonio, Texas.

CEO	Ms. Maria Zannes J.D.
WEBSITE	bioaffinitytech.com
SECTOR	Healthcare
INDUSTRY	Diagnostics & Research
EMPLOYEES	14

bioAffinity Technologies, Inc. Frequently Asked Questions

What is the ticker symbol for bioAffinity Technologies, Inc.? What does BIAF stand for in stocks?

BIAF is the stock ticker symbol of bioAffinity Technologies, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of bioAffinity Technologies, Inc. (BIAF)?

As of Mon Oct 21 2024, market cap of bioAffinity Technologies, Inc. is 19.37 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of BIAF stock?

You can check BIAF's fair value in chart for subscribers.

Is bioAffinity Technologies, Inc. a good stock to buy?

The fair value guage provides a quick view whether BIAF is over valued or under valued. Whether bioAffinity Technologies, Inc. is cheap or expensive depends on the assumptions which impact bioAffinity Technologies, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BIAF.

What is bioAffinity Technologies, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Mon Oct 21 2024, BIAF's PE ratio (Price to Earnings) is -2.22 and Price to Sales (PS) ratio is 2.65. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. BIAF PE ratio will change depending on the future growth rate expectations of investors.